Capsule Summary Slidesets

Share

Program Content

Activities

  • Imbokodo Vaccine Study
    Imbokodo: Phase IIb Trial of Heterologous HIV-1 Vaccine Regimen Among Women in Sub-Saharan Africa at High Risk for HIV Infection
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 17, 2022

    Expires: February 16, 2023

  • Cognitive Impairment
    ACTG A5324: Intensification of ART in People With HIV on Suppressive ART Does Not Improve Cognitive Impairment
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 17, 2022

    Expires: February 16, 2023

  • VISEND Study
    VISEND: Switching From NNRTI-Based to PI-Based ART vs DTG + Recycled NRTIs
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 22, 2022

    Expires: February 21, 2023

  • NADIA: DTG Second-line ART
    NADIA: Wk 96 Results With DTG vs DRV/RTV and TDF vs ZDV as Second-line ART in Africa
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 18, 2022

    Expires: February 17, 2023

  • CALIBRATE Primary Analysis
    CALIBRATE: Wk 54 Primary Analysis of Long-Acting Subcutaneous Lenacapavir in Treatment-Naive Patients
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 18, 2022

    Expires: February 17, 2023

  • SALSA Post hoc Analysis
    SALSA Post hoc Analysis: Proportion of Patients With Baseline Archived Resistance Attaining Stringent Efficacy Criteria After Switch to DTG/3TC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 16, 2022

    Expires: February 15, 2023

  • CAPELLA
    CAPELLA: Wk 52 Results With Long-acting SC Lenacapavir in Persons With Multidrug-Resistant HIV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 17, 2022

    Expires: February 16, 2023

  • HIV and Pregnancy Prevention
    Feasibility of Long-Acting Combination HIV and Pregnancy Prevention Implant Demonstrated in Mouse Model
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 18, 2022

    Expires: February 17, 2023

  • Monthly Islatravir for PrEP
    Protocol 016: Wk 24 Metabolic and Renal Outcomes Similar for Monthly Oral Islatravir vs Placebo as HIV PrEP in Phase IIa Study
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 16, 2022

    Expires: February 15, 2023

  • HPTN 083 Update
    HPTN 083: Updated Safety and Efficacy of Long-Acting Injectable CAB vs Daily Oral FTC/TDF as HIV PrEP in MSM and TGW
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 18, 2022

    Expires: February 17, 2023

Provided by

ProCE Banner

Supporters

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare